MENU

SLNO

Stock ticker:

PRICE

CHANGE

CAPITALIZATION

Soleno Therapeutics (SLNO) Ownership - Who owns Soleno Therapeutics?

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases... Show more

Industry: #Medical Specialties

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Medical Specialties

Address

100 Marine Parkway

Phone

+1 650 213-8444

Employees

182

Web

https://www.soleno.life

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

2.76B

P/E Ratio

27.47

Total Cash

255.6M

Projected Growth

N/A

Total Debt

54.28M

Revenue

285.01M

Risk (Beta)

-5.71

Dividend Yield

N/A

Total Cash/Share

4.90

Total Debt/Equity

N/A

Revenue/Share

5.27 USD as % of share price

View a ticker or compare two or three

VS

VS

SLNO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SLNO

A.I. Advisor

published General Information

General Information

a developer of medical diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow

Industry Biotechnology

Profile

Details

Industry

Medical Specialties

Address

100 Marine Parkway

Phone

+1 650 213-8444

Employees

182

Web

https://www.soleno.life